Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size, Status and Forecast 2019-2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Type (2014-2025)
- 1.4.2 VEGF-A Inhibitor
- 1.4.3 VEGF-B Inhibitor
- 1.4.4 VEGF-C Inhibitor
- 1.4.5 VEGF-D Inhibitor
- 1.5 Market by Application
- 1.5.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2019-2025)
- 1.5.2 Oncology
- 1.5.3 Ophthalmology
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size
- 2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Growth Trends by Regions
- 2.2.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Regions (2019-2025)
- 2.2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by by Players
- 3.1.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue by by Players (2014-2019)
- 3.1.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Concentration Ratio (CR5 and HHI)
- 3.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players Head office and Area Served
- 3.3 Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Product/Solution/Service
- 3.4 Date of Enter into Vascular Endothelial Growth Factor (VEGF) Inhibitors Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2014-2019)
- 4.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2014-2019)
5 North America
- 5.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
- 5.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in North America
- 5.3 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
- 5.4 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
6 Europe
- 6.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
- 6.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in Europe
- 6.3 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
- 6.4 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
7 China
- 7.1 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
- 7.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in China
- 7.3 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
- 7.4 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
8 Japan
- 8.1 Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
- 8.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in Japan
- 8.3 Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
- 8.4 Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
- 9.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in Southeast Asia
- 9.3 Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
- 9.4 Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
10 India
- 10.1 India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
- 10.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in India
- 10.3 India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
- 10.4 India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
11 Central & South America
- 11.1 Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
- 11.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in Central & South America
- 11.3 Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
- 11.4 Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
12 International Players Profiles
- 12.1 Bayer AG
- 12.1.1 Bayer AG Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
- 12.1.4 Bayer AG Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019))
- 12.1.5 Bayer AG Recent Development
- 12.2 F. Hoffmann-La Roche Ltd.
- 12.2.1 F. Hoffmann-La Roche Ltd. Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
- 12.2.4 F. Hoffmann-La Roche Ltd. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
- 12.2.5 F. Hoffmann-La Roche Ltd. Recent Development
- 12.3 Novartis AG
- 12.3.1 Novartis AG Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
- 12.3.4 Novartis AG Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
- 12.3.5 Novartis AG Recent Development
- 12.4 Regeneron Pharmaceuticals Inc.
- 12.4.1 Regeneron Pharmaceuticals Inc. Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
- 12.4.4 Regeneron Pharmaceuticals Inc. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
- 12.4.5 Regeneron Pharmaceuticals Inc. Recent Development
- 12.5 Sanofi.
- 12.5.1 Sanofi. Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
- 12.5.4 Sanofi. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
- 12.5.5 Sanofi. Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Vascular endothelial growth factor inhibitors, also known as angiogenesis inhibitors, can prevent the generation of new blood vessels.
The vascular endothelial growth factor is a protein that can trigger endothelial cells or pre-existing vessels to form new blood vessels. However, overexpression of vascular endothelial growth factor can generate cancerous cells.
In 2018, the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Vascular Endothelial Growth Factor (VEGF) Inhibitors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Vascular Endothelial Growth Factor (VEGF) Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Bayer AG
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Sanofi.
...
Market segment by Type, the product can be split into
VEGF-A Inhibitor
VEGF-B Inhibitor
VEGF-C Inhibitor
VEGF-D Inhibitor
Market segment by Application, split into
Oncology
Ophthalmology
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Vascular Endothelial Growth Factor (VEGF) Inhibitors status, future forecast, growth opportunity, key market and key players.
To present the Vascular Endothelial Growth Factor (VEGF) Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Vascular Endothelial Growth Factor (VEGF) Inhibitors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.